FDA Bans Red Dye No. 3: A Significant Step for Consumer Health and Safety
The U.S. Food and Drug Administration (FDA) has officially banned red dye No. 3 from food, beverages, and ingested drugs, a decision announced recently that comes more than 30 years after studies linked the dye to cancer in animals. This synthetic color, known chemically as erythrosine, is primarily used to impart a vibrant cherry-red hue to various products.
This action follows a petition from advocacy groups, including the Center for Science in the Public Interest and the Environmental Working Group, which highlighted the dye's potential health risks. California's government also took a similar step by banning the additive in October 2023.
Manufacturers will have until January 15, 2027, to reformulate food products and until January 18, 2028, for ingested drugs. Importers must also comply with the new regulations. Dr. Jerold Mande from Harvard University welcomed the FDA's decision as a significant step forward for public health.
Red dye No. 3 has been found in numerous candies and food products, but many brands, such as Ferrara and Just Born, have already reduced or eliminated its use. While some companies are shifting to red dye No. 40, this alternative has faced scrutiny as well, particularly in California, where similar health concerns have prompted its restriction in public schools.
Although there have been no confirmed studies linking red dye No. 3 to cancer in humans, experts argue that the FDA's mandate under the Delaney Clause requires the removal of additives that cause cancer in animals. The FDA had previously banned the dye in cosmetics and topical drugs in 1990 due to its carcinogenic properties in lab tests.
Despite the lack of direct evidence in humans, experts like Dr. Jennifer Pomeranz underscore the importance of adhering to the Delaney Clause, emphasizing that any cancer risk found in animals should disqualify the additive from food products. Additionally, various studies have raised concerns about the safety of red dye No. 3, including its potential impact on children's behavior and health.
The FDA's recent decision aligns U.S. regulations closer to those of the European Union, which banned red dye No. 3 in 1994. Critics have pointed out that the FDA's delay in taking action raises questions about its regulatory effectiveness.
At least 10 other states are considering similar bans, reflecting growing public concern over food safety. Advocates argue that the food industry has prioritized profit over public health, leading to a need for more rigorous research and funding to assess the risks associated with additives like red dye No. 3.
In response to the ban, the National Confectioners Association emphasized the importance of food safety and called for increased support for the FDA. Meanwhile, consumers are advised to check ingredient labels for red dye No. 3, also known as "red 3" or "FD&C Red #3," and to consider avoiding ultraprocessed foods where this dye commonly appears.
For medications, individuals should be vigilant about inactive ingredients and consult with healthcare providers for dye-free alternatives. The FDA’s actions mark a pivotal moment in consumer health advocacy, signaling a commitment to safety in food regulations.
2026-10-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
The FDA Officially Blesses AI for Liver Drug Development
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
FDA Dye Tracker Raises Reformulation Pressure Across Food Brands
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
-
Brazil Expands Chemical Tax Breaks as India’s Crop Protection Industry Warns of a 25% Cost Increase
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
U.S. Congress Passes Bill Authorizing Tariffs of Up to 100% on Major Buyers of Russian Energy
Recommend Reading
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
Multiple Positive Factors Drive Significant Increase in MTBE Market in China
-
Business Society September 24, 2026 PTA Trend Analysis: Clear Downtrend
-
Recent Acetic Acid Market Prices Have Risen Significantly in China
-
Business Society September 24, 2026 Acrylonitrile Trend Analysis: Volatility
-
March Acetic Acid Market Strongly Rises in China
- Hot Searches
- benzene and styrene prices
- sulphuric acid price
- calcium ammonium nitrate for sale
- where can you buy aniracetam
- ethane-1 2-diol
- sodium lauryl ether sulphate suppliers
- buy lignin
- retatrutide peptide buy usa price
- fasoracetam buy
- ammonia price index
- tergitol 91-6
- methyl ethyl ketone peroxide mekp